Exhibit 21
List of Subsidiaries
Entity Name | Place of Incorporation | Ownership % as of December 31, 2021 |
BridgeBio Pharma LLC | Delaware | 100.0% |
Adrenas Therapeutics, Inc. | Delaware | 98.8% |
Aspa Therapeutics, Inc. | Delaware | 97.3% |
Audition Therapeutics, Inc. | Delaware | 46.7% |
BB Square Capital Investors I, LP | Delaware | 100.0% |
BB Square Capital, LLC | Delaware | 100.0% |
BB Square Holdings, LLC | Delaware | 100.0% |
BB Square Investors GP I, LLC | Delaware | 100.0% |
BB Square LP Investment, LLC | Delaware | 100.0% |
BridgeBio Chemistry, Inc. | Delaware | 100.0% |
BridgeBio Gene Therapy LLC | Delaware | 100.0% |
BridgeBio Gene Therapy Research, Inc. | Delaware | 100.0% |
BridgeBio Services, Inc. | Delaware | 100.0% |
Calcilytix Therapeutics, Inc. | Delaware | 100.0% |
Cantero Therapeutics, Inc. | Delaware | 94.5% |
CoA Therapeutics, Inc. | Delaware | 99.9% |
Contour Therapeutics LLC | Delaware | 70.0% |
Cyan Therapeutics, Inc. | Delaware | 100.0% |
DTD Therapeutics, Inc. | Delaware | 100.0% |
Eidos Therapeutics, Inc. | Delaware | 100.0% |
Ferro Therapeutics, Inc. | Delaware | 98.3% |
G Protein Therapeutics. Inc. | Delaware | 93.0% |
ML Bio Solutions Inc. | Delaware | 72.4% |
Molecular Skin Therapeutics, Inc. | Delaware | 90.9% |
Navire Pharma, Inc. | Delaware | 79.5% |
Origin Biosciences, Inc. | Delaware | 99.9% |
PellePharm, Inc. | Delaware | 43.2% |
Phoenix Tissue Repair, Inc. | Delaware | 85.6% |
Portal Therapeutics, Inc. | Delaware | 99.5% |
QED Therapeutics, Inc. | Delaware | 98.9% |
Shift Therapeutics, Inc. | Delaware | 83.1% |
Sub20, Inc. | Delaware | 100.0% |
Sub21, Inc. | Delaware | 98.0% |
Sub22, Inc. | Delaware | 97.0% |
TheRas, Inc. | Delaware | 99.8% |
Venthera, Inc. | Delaware | 95.7% |
BridgeBio Pharma Canada, ULC | Canada | 100.0% |
BridgeBio Pharma Cayman | Cayman Islands | 100.0% |
BridgeBio Pharma (HK) Limited | Hong Kong | 100.0% |
BridgeBio Europe B.V. | Netherlands | 100.0% |
BridgeBio France SAS | France | 100.0% |
BridgeBio Germany, GmbH | Germany | 100.0% |
BridgeBio International GmbH | Switzerland | 100.0% |
BridgeBio UK Limited | United Kingdom | 100.0% |